In a potential boost for J&J’s serially underperforming Medical device division, it is reportedly buying Shockwave Medical, the market leader in intravascular lithotripsy, a minimally invasive technique to tackle calcium deposits in coronary arteries (atherosclerosis) via sound pressure waves
‘Santa Clara, Calif.-based Shockwave makes medical devices that treat cardiovascular diseases. In February, it projected revenue for 2024 that would range from $910 million to $930 million, which would be a roughly 27% increase from the previous year.’
https://www.wsj.com/health/healthcare/johnson-johnson-considers-deal-for-shockwave-medical-6fc59127